Early test of On-Demand vaginal insert aims to block HIV and herpes
NCT ID NCT06087913
Summary
This early-stage study tested the safety and acceptability of a vaginal insert containing two antiviral drugs. The insert is intended to be used on-demand around the time of sex to help prevent HIV and herpes infections. The study involved 68 healthy women who used the insert or a placebo for about two weeks while researchers monitored for side effects and drug levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SAFETY ISSUES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CAPRISA eThekwini Clinical Research Site
Durban, South Africa
-
Eastern Virginia Medical School Clinical Research Clinic (EVMS CRC)
Norfolk, Virginia, 23507, United States
-
Kenya Medical Research Institute (KEMRI)
Thika, Kenya
Conditions
Explore the condition pages connected to this study.